APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sleep Disorder Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sleep Disorder Treatment Drugs Industry Growth and Trends Forecast to 2032

22 December 2025125 pages

Choose your research edition.

Industry ResearchSleep Disorder Treatment Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Sleep Disorder Treatment Drugs Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Sleep Disorder Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sleep Disorder Treatment Drugs Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Sleep Disorder Treatment Drugs Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Sleep Disorder Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sleep Disorder Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sleep Disorder Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sleep Disorder Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sleep Disorder Treatment Drugs include Takeda Pharmaceutical Company, Eisai, Teva Pharmaceutical Industries Ltd., Sanofi, Merck, Pfizer, GlaxoSmithKline, ZYDUS CADILA GROUP and Natus Medicalorporated, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sleep Disorder Treatment Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sleep Disorder Treatment Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sleep Disorder Treatment Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sleep Disorder Treatment Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sleep Disorder Treatment Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sleep Disorder Treatment Drugs Market by Company

Takeda Pharmaceutical Company

Eisai

Teva Pharmaceutical Industries Ltd.

Sanofi

Merck

Pfizer

GlaxoSmithKline

ZYDUS CADILA GROUP

Natus Medicalorporated

Mylan N.V.

Leva Pharmaceutical Industries

Koninklijke Philips

Heptares Therapeutics (Sosei Group Corporation)

Galenica

Ferring International Center

Evotec

Cardinal Health

Becton Dickson and Company

Athenex

Astellas Pharma

Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)

Sleep Disorder Treatment Drugs Segment by Type

Herbal Drugs

Prescription-based Drugs

OTC Drugs

Sleep Disorder Treatment Drugs Segment by Application

Clinics

Hospitals

Research Centers

Others

Sleep Disorder Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sleep Disorder Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sleep Disorder Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sleep Disorder Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sleep Disorder Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sleep Disorder Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Herbal Drugs Table 2. Major Company of Prescription-based Drugs Table 3. Major Company of OTC Drugs Table 4. Global Sleep Disorder Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 6. Global Sleep Disorder Treatment Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Sleep Disorder Treatment Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Sleep Disorder Treatment Drugs Price by Type (2021-2026) & (US$/unit) Table 10. Global Sleep Disorder Treatment Drugs Sales by Type (2027-2032) & (k units) Table 11. Global Sleep Disorder Treatment Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Sleep Disorder Treatment Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Sleep Disorder Treatment Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Sleep Disorder Treatment Drugs Price by Type (2027-2032) & (US$/unit) Table 15. North America Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 16. North America Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 18. Europe Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 22. Latin America Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Sleep Disorder Treatment Drugs Industry Trends Table 26. Sleep Disorder Treatment Drugs Industry Drivers Table 27. Sleep Disorder Treatment Drugs Industry Opportunities and Challenges Table 28. Sleep Disorder Treatment Drugs Industry Restraints Table 29. Global Sleep Disorder Treatment Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Sleep Disorder Treatment Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Sleep Disorder Treatment Drugs Sales by Company (2021-2026) & (k units) Table 32. Global Sleep Disorder Treatment Drugs Sales Share by Company (2021-2026) Table 33. Global Sleep Disorder Treatment Drugs Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Sleep Disorder Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Sleep Disorder Treatment Drugs Major Company Production Sites and Headquarters Table 36. Global Sleep Disorder Treatment Drugs Company, Product Type & Application Table 37. Global Sleep Disorder Treatment Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Sleep Disorder Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Sleep Disorder Treatment Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Sleep Disorder Treatment Drugs Sales by Region (2021-2026) & (k units) Table 42. Global Sleep Disorder Treatment Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Sleep Disorder Treatment Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Sleep Disorder Treatment Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Sleep Disorder Treatment Drugs Sales by Region (2027-2032) & (k units) Table 47. Global Sleep Disorder Treatment Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Sleep Disorder Treatment Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Sleep Disorder Treatment Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Sleep Disorder Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Sleep Disorder Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 53. Global Sleep Disorder Treatment Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Sleep Disorder Treatment Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Sleep Disorder Treatment Drugs Price by Application (2021-2026) & (US$/unit) Table 57. Global Sleep Disorder Treatment Drugs Sales by Application (2027-2032) & (k units) Table 58. Global Sleep Disorder Treatment Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Sleep Disorder Treatment Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Sleep Disorder Treatment Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Sleep Disorder Treatment Drugs Price by Application (2027-2032) & (US$/unit) Table 62. North America Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 63. North America Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 65. Europe Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 69. Latin America Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Takeda Pharmaceutical Company Company Information Table 73. Takeda Pharmaceutical Company Business Overview Table 74. Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Product Portfolio Table 76. Takeda Pharmaceutical Company Recent Development Table 77. Eisai Company Information Table 78. Eisai Business Overview Table 79. Eisai Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Eisai Sleep Disorder Treatment Drugs Product Portfolio Table 81. Eisai Recent Development Table 82. Teva Pharmaceutical Industries Ltd. Company Information Table 83. Teva Pharmaceutical Industries Ltd. Business Overview Table 84. Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Product Portfolio Table 86. Teva Pharmaceutical Industries Ltd. Recent Development Table 87. Sanofi Company Information Table 88. Sanofi Business Overview Table 89. Sanofi Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Sanofi Sleep Disorder Treatment Drugs Product Portfolio Table 91. Sanofi Recent Development Table 92. Merck Company Information Table 93. Merck Business Overview Table 94. Merck Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Merck Sleep Disorder Treatment Drugs Product Portfolio Table 96. Merck Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Pfizer Sleep Disorder Treatment Drugs Product Portfolio Table 101. Pfizer Recent Development Table 102. GlaxoSmithKline Company Information Table 103. GlaxoSmithKline Business Overview Table 104. GlaxoSmithKline Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Sleep Disorder Treatment Drugs Product Portfolio Table 106. GlaxoSmithKline Recent Development Table 107. ZYDUS CADILA GROUP Company Information Table 108. ZYDUS CADILA GROUP Business Overview Table 109. ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Product Portfolio Table 111. ZYDUS CADILA GROUP Recent Development Table 112. Natus Medicalorporated Company Information Table 113. Natus Medicalorporated Business Overview Table 114. Natus Medicalorporated Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Natus Medicalorporated Sleep Disorder Treatment Drugs Product Portfolio Table 116. Natus Medicalorporated Recent Development Table 117. Mylan N.V. Company Information Table 118. Mylan N.V. Business Overview Table 119. Mylan N.V. Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Mylan N.V. Sleep Disorder Treatment Drugs Product Portfolio Table 121. Mylan N.V. Recent Development Table 122. Leva Pharmaceutical Industries Company Information Table 123. Leva Pharmaceutical Industries Business Overview Table 124. Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Product Portfolio Table 126. Leva Pharmaceutical Industries Recent Development Table 127. Koninklijke Philips Company Information Table 128. Koninklijke Philips Business Overview Table 129. Koninklijke Philips Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Koninklijke Philips Sleep Disorder Treatment Drugs Product Portfolio Table 131. Koninklijke Philips Recent Development Table 132. Heptares Therapeutics (Sosei Group Corporation) Company Information Table 133. Heptares Therapeutics (Sosei Group Corporation) Business Overview Table 134. Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Product Portfolio Table 136. Heptares Therapeutics (Sosei Group Corporation) Recent Development Table 137. Galenica Company Information Table 138. Galenica Business Overview Table 139. Galenica Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Galenica Sleep Disorder Treatment Drugs Product Portfolio Table 141. Galenica Recent Development Table 142. Ferring International Center Company Information Table 143. Ferring International Center Business Overview Table 144. Ferring International Center Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. Ferring International Center Sleep Disorder Treatment Drugs Product Portfolio Table 146. Ferring International Center Recent Development Table 147. Evotec Company Information Table 148. Evotec Business Overview Table 149. Evotec Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 150. Evotec Sleep Disorder Treatment Drugs Product Portfolio Table 151. Evotec Recent Development Table 152. Cardinal Health Company Information Table 153. Cardinal Health Business Overview Table 154. Cardinal Health Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 155. Cardinal Health Sleep Disorder Treatment Drugs Product Portfolio Table 156. Cardinal Health Recent Development Table 157. Becton Dickson and Company Company Information Table 158. Becton Dickson and Company Business Overview Table 159. Becton Dickson and Company Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 160. Becton Dickson and Company Sleep Disorder Treatment Drugs Product Portfolio Table 161. Becton Dickson and Company Recent Development Table 162. Athenex Company Information Table 163. Athenex Business Overview Table 164. Athenex Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 165. Athenex Sleep Disorder Treatment Drugs Product Portfolio Table 166. Athenex Recent Development Table 167. Astellas Pharma Company Information Table 168. Astellas Pharma Business Overview Table 169. Astellas Pharma Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 170. Astellas Pharma Sleep Disorder Treatment Drugs Product Portfolio Table 171. Astellas Pharma Recent Development Table 172. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Company Information Table 173. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Business Overview Table 174. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 175. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Product Portfolio Table 176. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Recent Development Table 177. North America Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 178. North America Sleep Disorder Treatment Drugs Sales by Country (2021-2026) & (k units) Table 179. North America Sleep Disorder Treatment Drugs Sales Market Share by Country (2021-2026) Table 180. North America Sleep Disorder Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 181. North America Sleep Disorder Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 182. North America Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. North America Sleep Disorder Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 184. North America Sleep Disorder Treatment Drugs Market Share by Country (2021-2026) Table 185. North America Sleep Disorder Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. North America Sleep Disorder Treatment Drugs Market Share Forecast by Country (2027-2032) Table 187. Europe Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 188. Europe Sleep Disorder Treatment Drugs Sales by Country (2021-2026) & (k units) Table 189. Europe Sleep Disorder Treatment Drugs Sales Market Share by Country (2021-2026) Table 190. Europe Sleep Disorder Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 191. Europe Sleep Disorder Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 192. Europe Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Europe Sleep Disorder Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 194. Europe Sleep Disorder Treatment Drugs Market Share by Country (2021-2026) Table 195. Europe Sleep Disorder Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Europe Sleep Disorder Treatment Drugs Market Share Forecast by Country (2027-2032) Table 197. Asia-Pacific Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 198. Asia-Pacific Sleep Disorder Treatment Drugs Sales by Country (2021-2026) & (k units) Table 199. Asia-Pacific Sleep Disorder Treatment Drugs Sales Market Share by Country (2021-2026) Table 200. Asia-Pacific Sleep Disorder Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 201. Asia-Pacific Sleep Disorder Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 202. Asia-Pacific Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Asia-Pacific Sleep Disorder Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 204. Asia-Pacific Sleep Disorder Treatment Drugs Market Share by Country (2021-2026) Table 205. Asia-Pacific Sleep Disorder Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Asia-Pacific Sleep Disorder Treatment Drugs Market Share Forecast by Country (2027-2032) Table 207. Latin America Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 208. Latin America Sleep Disorder Treatment Drugs Sales by Country (2021-2026) & (k units) Table 209. Latin America Sleep Disorder Treatment Drugs Sales Market Share by Country (2021-2026) Table 210. Latin America Sleep Disorder Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 211. Latin America Sleep Disorder Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 212. Latin America Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. Latin America Sleep Disorder Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 214. Latin America Sleep Disorder Treatment Drugs Market Share by Country (2021-2026) Table 215. Latin America Sleep Disorder Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. Latin America Sleep Disorder Treatment Drugs Market Share Forecast by Country (2027-2032) Table 217. Middle East and Africa Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 218. Middle East and Africa Sleep Disorder Treatment Drugs Sales by Country (2021-2026) & (k units) Table 219. Middle East and Africa Sleep Disorder Treatment Drugs Sales Market Share by Country (2021-2026) Table 220. Middle East and Africa Sleep Disorder Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 221. Middle East and Africa Sleep Disorder Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 222. Middle East and Africa Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 223. Middle East and Africa Sleep Disorder Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 224. Middle East and Africa Sleep Disorder Treatment Drugs Market Share by Country (2021-2026) Table 225. Middle East and Africa Sleep Disorder Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 226. Middle East and Africa Sleep Disorder Treatment Drugs Market Share Forecast by Country (2027-2032) Table 227. Key Raw Materials Table 228. Raw Materials Key Suppliers Table 229. Sleep Disorder Treatment Drugs Distributors List Table 230. Sleep Disorder Treatment Drugs Customers List Table 231. Research Programs/Design for This Report Table 232. Authors List of This Report Table 233. Secondary Sources Table 234. Primary Sources List of Figures Figure 1. Sleep Disorder Treatment Drugs Image Figure 2. Global Sleep Disorder Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sleep Disorder Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Sleep Disorder Treatment Drugs Sales (2021-2032) & (k units) Figure 5. Herbal Drugs Image Figure 6. Global Herbal Drugs Sales YoY Growth (2021-2032) & (k units) Figure 7. Prescription-based Drugs Image Figure 8. Global Prescription-based Drugs Sales YoY Growth (2021-2032) & (k units) Figure 9. OTC Drugs Image Figure 10. Global OTC Drugs Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Sleep Disorder Treatment Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Sleep Disorder Treatment Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Sleep Disorder Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Sleep Disorder Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Sleep Disorder Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Sleep Disorder Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Sleep Disorder Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Sleep Disorder Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Sleep Disorder Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Sleep Disorder Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Sleep Disorder Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Sleep Disorder Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Sleep Disorder Treatment Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 29. Research Centers Image Figure 30. Global Research Centers Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Sleep Disorder Treatment Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Sleep Disorder Treatment Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Sleep Disorder Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Sleep Disorder Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Sleep Disorder Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Sleep Disorder Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Sleep Disorder Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Sleep Disorder Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Sleep Disorder Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Sleep Disorder Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Sleep Disorder Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Sleep Disorder Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Sleep Disorder Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Sleep Disorder Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Sleep Disorder Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Sleep Disorder Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Sleep Disorder Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Sleep Disorder Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Sleep Disorder Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Sleep Disorder Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Sleep Disorder Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Sleep Disorder Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Sleep Disorder Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Sleep Disorder Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Sleep Disorder Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Sleep Disorder Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Sleep Disorder Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Sleep Disorder Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Sleep Disorder Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Sleep Disorder Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Sleep Disorder Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Sleep Disorder Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Sleep Disorder Treatment Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Sleep Disorder Treatment Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Herbal Drugs
  • Prescription-based Drugs
  • OTC Drugs
Applications
  • Clinics
  • Hospitals
  • Research Centers
  • Others
Companies covered
  • Takeda Pharmaceutical Company
  • Eisai
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • ZYDUS CADILA GROUP
  • Natus Medicalorporated
  • Mylan N.V.
  • Leva Pharmaceutical Industries
  • Koninklijke Philips
  • Heptares Therapeutics (Sosei Group Corporation)
  • Galenica
  • Ferring International Center
  • Evotec
  • Cardinal Health
  • Becton Dickson and Company
  • Athenex
  • Astellas Pharma
  • Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sleep Disorder Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sleep Disorder Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sleep Disorder Treatment Drugs Market by Type
  6. 1.3.1 Herbal Drugs
  7. 1.3.2 Prescription-based Drugs
  8. 1.3.3 OTC Drugs
  9. 1.4 Global Sleep Disorder Treatment Drugs Market Size by Type
  10. 1.4.1 Global Sleep Disorder Treatment Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Sleep Disorder Treatment Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Sleep Disorder Treatment Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Sleep Disorder Treatment Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Sleep Disorder Treatment Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Sleep Disorder Treatment Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Sleep Disorder Treatment Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Sleep Disorder Treatment Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sleep Disorder Treatment Drugs Industry Trends
  2. 2.2 Sleep Disorder Treatment Drugs Industry Drivers
  3. 2.3 Sleep Disorder Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Sleep Disorder Treatment Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sleep Disorder Treatment Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Sleep Disorder Treatment Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Sleep Disorder Treatment Drugs Price (2021-2026)
  4. 3.4 Global Sleep Disorder Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sleep Disorder Treatment Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Sleep Disorder Treatment Drugs Company, Product Type & Application
  7. 3.7 Global Sleep Disorder Treatment Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sleep Disorder Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sleep Disorder Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sleep Disorder Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Sleep Disorder Treatment Drugs Regional Status and Outlook
  1. 4.1 Global Sleep Disorder Treatment Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sleep Disorder Treatment Drugs Historic Market Size by Region
  3. 4.2.1 Global Sleep Disorder Treatment Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sleep Disorder Treatment Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sleep Disorder Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sleep Disorder Treatment Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Sleep Disorder Treatment Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sleep Disorder Treatment Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sleep Disorder Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sleep Disorder Treatment Drugs by Application
  1. 5.1 Sleep Disorder Treatment Drugs Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Research Centers
  5. 5.1.4 Others
  6. 5.2 Global Sleep Disorder Treatment Drugs Market Size by Application
  7. 5.2.1 Global Sleep Disorder Treatment Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Sleep Disorder Treatment Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Sleep Disorder Treatment Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Sleep Disorder Treatment Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Sleep Disorder Treatment Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Sleep Disorder Treatment Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Sleep Disorder Treatment Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Sleep Disorder Treatment Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Company
  2. 6.1.1 Takeda Pharmaceutical Company Company Information
  3. 6.1.2 Takeda Pharmaceutical Company Business Overview
  4. 6.1.3 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Sleep Disorder Treatment Drugs Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Teva Pharmaceutical Industries Ltd.
  14. 6.3.1 Teva Pharmaceutical Industries Ltd. Company Information
  15. 6.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
  16. 6.3.3 Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Product Portfolio
  18. 6.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Sleep Disorder Treatment Drugs Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Sleep Disorder Treatment Drugs Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Sleep Disorder Treatment Drugs Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Sleep Disorder Treatment Drugs Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 ZYDUS CADILA GROUP
  44. 6.8.1 ZYDUS CADILA GROUP Company Information
  45. 6.8.2 ZYDUS CADILA GROUP Business Overview
  46. 6.8.3 ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Product Portfolio
  48. 6.8.5 ZYDUS CADILA GROUP Recent Developments
  49. 6.9 Natus Medicalorporated
  50. 6.9.1 Natus Medicalorporated Company Information
  51. 6.9.2 Natus Medicalorporated Business Overview
  52. 6.9.3 Natus Medicalorporated Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Natus Medicalorporated Sleep Disorder Treatment Drugs Product Portfolio
  54. 6.9.5 Natus Medicalorporated Recent Developments
  55. 6.10 Mylan N.V.
  56. 6.10.1 Mylan N.V. Company Information
  57. 6.10.2 Mylan N.V. Business Overview
  58. 6.10.3 Mylan N.V. Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mylan N.V. Sleep Disorder Treatment Drugs Product Portfolio
  60. 6.10.5 Mylan N.V. Recent Developments
  61. 6.11 Leva Pharmaceutical Industries
  62. 6.11.1 Leva Pharmaceutical Industries Company Information
  63. 6.11.2 Leva Pharmaceutical Industries Business Overview
  64. 6.11.3 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Product Portfolio
  66. 6.11.5 Leva Pharmaceutical Industries Recent Developments
  67. 6.12 Koninklijke Philips
  68. 6.12.1 Koninklijke Philips Company Information
  69. 6.12.2 Koninklijke Philips Business Overview
  70. 6.12.3 Koninklijke Philips Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Koninklijke Philips Sleep Disorder Treatment Drugs Product Portfolio
  72. 6.12.5 Koninklijke Philips Recent Developments
  73. 6.13 Heptares Therapeutics (Sosei Group Corporation)
  74. 6.13.1 Heptares Therapeutics (Sosei Group Corporation) Company Information
  75. 6.13.2 Heptares Therapeutics (Sosei Group Corporation) Business Overview
  76. 6.13.3 Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Product Portfolio
  78. 6.13.5 Heptares Therapeutics (Sosei Group Corporation) Recent Developments
  79. 6.14 Galenica
  80. 6.14.1 Galenica Company Information
  81. 6.14.2 Galenica Business Overview
  82. 6.14.3 Galenica Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Galenica Sleep Disorder Treatment Drugs Product Portfolio
  84. 6.14.5 Galenica Recent Developments
  85. 6.15 Ferring International Center
  86. 6.15.1 Ferring International Center Company Information
  87. 6.15.2 Ferring International Center Business Overview
  88. 6.15.3 Ferring International Center Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Ferring International Center Sleep Disorder Treatment Drugs Product Portfolio
  90. 6.15.5 Ferring International Center Recent Developments
  91. 6.16 Evotec
  92. 6.16.1 Evotec Company Information
  93. 6.16.2 Evotec Business Overview
  94. 6.16.3 Evotec Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Evotec Sleep Disorder Treatment Drugs Product Portfolio
  96. 6.16.5 Evotec Recent Developments
  97. 6.17 Cardinal Health
  98. 6.17.1 Cardinal Health Company Information
  99. 6.17.2 Cardinal Health Business Overview
  100. 6.17.3 Cardinal Health Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Cardinal Health Sleep Disorder Treatment Drugs Product Portfolio
  102. 6.17.5 Cardinal Health Recent Developments
  103. 6.18 Becton Dickson and Company
  104. 6.18.1 Becton Dickson and Company Company Information
  105. 6.18.2 Becton Dickson and Company Business Overview
  106. 6.18.3 Becton Dickson and Company Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Becton Dickson and Company Sleep Disorder Treatment Drugs Product Portfolio
  108. 6.18.5 Becton Dickson and Company Recent Developments
  109. 6.19 Athenex
  110. 6.19.1 Athenex Company Information
  111. 6.19.2 Athenex Business Overview
  112. 6.19.3 Athenex Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Athenex Sleep Disorder Treatment Drugs Product Portfolio
  114. 6.19.5 Athenex Recent Developments
  115. 6.20 Astellas Pharma
  116. 6.20.1 Astellas Pharma Company Information
  117. 6.20.2 Astellas Pharma Business Overview
  118. 6.20.3 Astellas Pharma Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Astellas Pharma Sleep Disorder Treatment Drugs Product Portfolio
  120. 6.20.5 Astellas Pharma Recent Developments
  121. 6.21 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)
  122. 6.21.1 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Company Information
  123. 6.21.2 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Business Overview
  124. 6.21.3 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Product Portfolio
  126. 6.21.5 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Recent Developments
7 North America by Country
  1. 7.1 North America Sleep Disorder Treatment Drugs Sales by Country
  2. 7.1.1 North America Sleep Disorder Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sleep Disorder Treatment Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Sleep Disorder Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sleep Disorder Treatment Drugs Market Size by Country
  6. 7.2.1 North America Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sleep Disorder Treatment Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Sleep Disorder Treatment Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sleep Disorder Treatment Drugs Sales by Country
  2. 8.1.1 Europe Sleep Disorder Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sleep Disorder Treatment Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Sleep Disorder Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sleep Disorder Treatment Drugs Market Size by Country
  6. 8.2.1 Europe Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sleep Disorder Treatment Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sleep Disorder Treatment Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sleep Disorder Treatment Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Sleep Disorder Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sleep Disorder Treatment Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sleep Disorder Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sleep Disorder Treatment Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sleep Disorder Treatment Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sleep Disorder Treatment Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sleep Disorder Treatment Drugs Sales by Country
  2. 10.1.1 South America Sleep Disorder Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sleep Disorder Treatment Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Sleep Disorder Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sleep Disorder Treatment Drugs Market Size by Country
  6. 10.2.1 South America Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sleep Disorder Treatment Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Sleep Disorder Treatment Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sleep Disorder Treatment Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Sleep Disorder Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sleep Disorder Treatment Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sleep Disorder Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sleep Disorder Treatment Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sleep Disorder Treatment Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sleep Disorder Treatment Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sleep Disorder Treatment Drugs Value Chain Analysis
  2. 12.1.1 Sleep Disorder Treatment Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sleep Disorder Treatment Drugs Production Mode & Process
  7. 12.2 Sleep Disorder Treatment Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sleep Disorder Treatment Drugs Distributors
  10. 12.2.3 Sleep Disorder Treatment Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst